Curis CRIS
NASDAQ CRIS
$1.58 -0.03 (-1.86%)
At close: Aug 21, 2026 · 4:00 PM EDT

Curis (CRIS) Cash from Financing Activities (2010 - 2026)

Curis' (CRIS) quarterly Cash from Financing Activities came in at $18.9 million in Q1 2026, up 151.31% YoY from $7.5 million in Q1 2025, and up 16016.81% on a QoQ basis from -$119000.0 in Q4 2025.

Curis (CRIS) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Curis (CRIS) has 17 years of Cash from Financing Activities data on file, last reported at $18.9 million in Q1 2026.

  • Quarterly Cash from Financing Activities rose 151.31% year-over-year to $18.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.2 million (up 58.21% YoY) and the FY2025 annual result came in at $9.8 million, up 184.11% from the prior year.
  • Cash from Financing Activities improved to $18.9 million in Q1 2026, from -$119000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $18.9 million in Q1 2026 to a low of -$2.4 million in Q1 2024.
  • A 5-year average of $2.4 million and a median of -$852000.0 in 2023 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities jumped 587.66% — and 2024, when it sank 112.14%.
  • Tracing CRIS's Cash from Financing Activities over 5 years: stood at -$1.4 million in 2022, then slumped by 52.59% to -$2.1 million in 2023, then soared by 516.95% to $8.8 million in 2024, then slumped by 101.35% to -$119000.0 in 2025, then jumped by 16016.81% to $18.9 million in 2026.
  • The last three Cash from Financing Activities figures came in at $18.9 million (Q1 2026), -$119000.0 (Q4 2025), and $4.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 14.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -6.05 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 36.24 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 27.18 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -273.15 Mn
10 Curis 3.27 Mn -2.35 Mn - -282,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 18.94 Mn
Mar 31, 2026 18.94 Mn
Dec 31, 2025 -119,000.00
Dec 31, 2025 -119,000.00
Sep 30, 2025 4.48 Mn
Sep 30, 2025 4.48 Mn
Jun 30, 2025 -2.14 Mn
Jun 30, 2025 -2.14 Mn
Mar 31, 2025 7.54 Mn
Mar 31, 2025 7.54 Mn
Dec 31, 2024 8.83 Mn
Dec 31, 2024 8.83 Mn
Sep 30, 2024 -1.52 Mn
Sep 30, 2024 -1.52 Mn
Jun 30, 2024 -1.46 Mn
Jun 30, 2024 -1.46 Mn
Mar 31, 2024 -2.41 Mn
Mar 31, 2024 -2.41 Mn
Dec 31, 2023 -2.12 Mn
Dec 31, 2023 -2.12 Mn